“My goal is to provide the best care possible to my patients without exception. I value the opportunity and the privilege to care for cancer patients in a compassionate and humanistic way. I deeply enjoy the relationship I establish with my patients and their families and strive to treat each patient as if they were part of my family,” he says
Dr. Wiernik is a specialist trained in Internal Medicine, Hematology, Medical Oncology and Bone Marrow Transplantation. He studied medicine at UCIMED Medical School (Costa Rica), carried out his training in internal medicine at the Hennepin Healthcare System (Minnesota, USA), and his specialization in Hematology, Oncology and Bone Marrow Transplants at the University of Minnesota. During his training, he completed internships and fellowships at Harvard University (USA), the Karolinska Cancer Center (Sweden), the University of Turin (Italy), and the Peter MacCallum Cancer Center (Australia).
From 2014 to 2017, he was a member of the board of the Minnesota Society of Clinical Oncology, and has been named as one of the ‘Best Doctors’ in the area of Medical Oncology and Hematology of the State of Minnesota (2016, 2017 and 2018). He has also been selected as a "Rising Star" in the field (2018, 2019) by the Minneapolis-St Paul Magazine.
Dr. Wiernik is licensed to practice in the United States and holds Board Certifications in Internal Medicine, Hematology and Medical Oncology.
In addition to his role as medical director and specialist of the Cancer and Hematology Center of the Metropolitano Hospital, Dr. Wiernik continues to periodically treat patients at the Hennepin Healthcare System where he used to lead the Breast Cancer Committee. He is also an assistant professor of medicine at the University of Minnesota and UCIMED Medical School. His work as a teacher in the field has been recognized with a great number of awards.
Throughout his academic career he has published in prestigious medical journals. During his training at the University of Minnesota, he was the lead investigator in the development of an immunological therapy for the treatment of acute myeloid leukemia and myelodysplastic syndromes, which is currently under clinical trials.
Dr. Wiernik is a member of the College of Physicians and Surgeons of Costa Rica, and holds an MBA from Chicago Booth Business School.
Learn more about our director or schedule an appointment with him.
